These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 24292274)

  • 21. Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk.
    Crowther-Swanepoel D; Mansouri M; Enjuanes A; Vega A; Smedby KE; Ruiz-Ponte C; Jurlander J; Juliusson G; Montserrat E; Catovsky D; Campo E; Carracedo A; Rosenquist R; Houlston RS
    Br J Haematol; 2010 Aug; 150(4):473-9. PubMed ID: 20553269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic susceptibility to chronic lymphocytic leukemia.
    Slager SL; Caporaso NE; de Sanjose S; Goldin LR
    Semin Hematol; 2013 Oct; 50(4):296-302. PubMed ID: 24246697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
    Sava GP; Speedy HE; Di Bernardo MC; Deaglio S; Karabon L; Frydecka I; Woszczyk D; Rossi D; Gaidano G; Mansouri L; Smedby KE; Juliusson G; Rosenquist R; Catovsky D; Houlston RS
    Br J Haematol; 2013 Jul; 162(2):221-8. PubMed ID: 23668599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic lymphocytic leukemia (CLL) risk is mediated by multiple enhancer variants within CLL risk loci.
    Yan H; Tian S; Kleinstern G; Wang Z; Lee JH; Boddicker NJ; Cerhan JR; Kay NE; Braggio E; Slager SL
    Hum Mol Genet; 2020 Sep; 29(16):2761-2774. PubMed ID: 32744316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.
    Houlston RS; Cheadle J; Dobbins SE; Tenesa A; Jones AM; Howarth K; Spain SL; Broderick P; Domingo E; Farrington S; Prendergast JG; Pittman AM; Theodoratou E; Smith CG; Olver B; Walther A; Barnetson RA; Churchman M; Jaeger EE; Penegar S; Barclay E; Martin L; Gorman M; Mager R; Johnstone E; Midgley R; Niittymäki I; Tuupanen S; Colley J; Idziaszczyk S; ; Thomas HJ; Lucassen AM; Evans DG; Maher ER; ; ; ; Maughan T; Dimas A; Dermitzakis E; Cazier JB; Aaltonen LA; Pharoah P; Kerr DJ; Carvajal-Carmona LG; Campbell H; Dunlop MG; Tomlinson IP
    Nat Genet; 2010 Nov; 42(11):973-7. PubMed ID: 20972440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.
    Slager SL; Achenbach SJ; Asmann YW; Camp NJ; Rabe KG; Goldin LR; Call TG; Shanafelt TD; Kay NE; Cunningham JM; Wang AH; Weinberg JB; Norman AD; Link BK; Leis JF; Vachon CM; Lanasa MC; Caporaso NE; Novak AJ; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):461-6. PubMed ID: 23307532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia.
    Lin WY; Fordham SE; Sunter N; Elstob C; Rahman T; Willmore E; Shepherd C; Strathdee G; Mainou-Fowler T; Piddock R; Mearns H; Barrow T; Houlston RS; Marr H; Wallis J; Summerfield G; Marshall S; Pettitt A; Pepper C; Fegan C; Forconi F; Dyer MJS; Jayne S; Sellors A; Schuh A; Robbe P; Oscier D; Bailey J; Rais S; Bentley A; Cawkwell L; Evans P; Hillmen P; Pratt G; Allsup DJ; Allan JM
    Nat Commun; 2021 Jan; 12(1):665. PubMed ID: 33510140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic susceptibility variants for chronic lymphocytic leukemia.
    Slager SL; Goldin LR; Strom SS; Lanasa MC; Spector LG; Rassenti L; Leis JF; Camp NJ; Kay NE; Vachon CM; Glenn M; Weinberg JB; Rabe KG; Cunningham JM; Achenbach SJ; Hanson CA; Marti GE; Call TG; Caporaso NE; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1098-102. PubMed ID: 20332261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia.
    Sellick GS; Goldin LR; Wild RW; Slager SL; Ressenti L; Strom SS; Dyer MJ; Mauro FR; Marti GE; Fuller S; Lyttelton M; Kipps TJ; Keating MJ; Call TG; Catovsky D; Caporaso N; Houlston RS
    Blood; 2007 Nov; 110(9):3326-33. PubMed ID: 17687107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inherited susceptibility to CLL.
    Speedy HE; Sava G; Houlston RS
    Adv Exp Med Biol; 2013; 792():293-308. PubMed ID: 24014302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine mapping in TERT-CLPTM1L region identified three independent lung cancer susceptibility signals: A large-scale multi-ethnic population study.
    Li Z; Pu Z; Fan J; Li N; Zhu M; Zhang J; Wang Y; Geng L; Cheng Y; Ma H; Jin G; Dai J; Hu Z; Shen H
    Mol Carcinog; 2018 Oct; 57(10):1289-1299. PubMed ID: 29809284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TERT-rs33963617 and CLPTM1L-rs77518573 reduce the risk of non-small cell lung cancer in Chinese population.
    Ji Z; Li Y; Xiang C; Luo X; Yuan P; Long J; Shen N; Shen Y; Deng L; Li J; Cheng L
    Gene; 2020 Mar; 731():144357. PubMed ID: 31935503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.
    Went M; Sud A; Speedy H; Sunter NJ; Försti A; Law PJ; Johnson DC; Mirabella F; Holroyd A; Li N; Orlando G; Weinhold N; van Duin M; Chen B; Mitchell JS; Mansouri L; Juliusson G; Smedby KE; Jayne S; Majid A; Dearden C; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Rosenquist R; Kuiper R; Stephens OW; Bertsch U; Broderick P; Einsele H; Gregory WM; Hillengass J; Hoffmann P; Jackson GH; Jöckel KH; Nickel J; Nöthen MM; da Silva Filho MI; Thomsen H; Walker BA; Broyl A; Davies FE; Hansson M; Goldschmidt H; Dyer MJS; Kaiser M; Sonneveld P; Morgan GJ; Hemminki K; Nilsson B; Catovsky D; Allan JM; Houlston RS
    Blood Cancer J; 2018 Dec; 9(1):1. PubMed ID: 30602759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replication study in Chinese population and meta-analysis supports association of the 5p15.33 locus with lung cancer.
    Ke J; Zhong R; Zhang T; Liu L; Rui R; Shen N; Sun Y; Liu L; Cheng L; Miao XP
    PLoS One; 2013; 8(4):e62485. PubMed ID: 23653681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.
    Migliorini G; Fiege B; Hosking FJ; Ma Y; Kumar R; Sherborne AL; da Silva Filho MI; Vijayakrishnan J; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson P; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Zimmermann M; Bartram CR; Schrappe M; Greaves M; Stanulla M; Hemminki K; Houlston RS
    Blood; 2013 Nov; 122(19):3298-307. PubMed ID: 23996088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism.
    Kandaswamy R; Sava GP; Speedy HE; Beà S; Martín-Subero JI; Studd JB; Migliorini G; Law PJ; Puente XS; Martín-García D; Salaverria I; Gutiérrez-Abril J; López-Otín C; Catovsky D; Allan JM; Campo E; Houlston RS
    Cell Rep; 2016 Aug; 16(8):2061-2067. PubMed ID: 27524613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide association study identifies multiple loci associated with bladder cancer risk.
    Figueroa JD; Ye Y; Siddiq A; Garcia-Closas M; Chatterjee N; Prokunina-Olsson L; Cortessis VK; Kooperberg C; Cussenot O; Benhamou S; Prescott J; Porru S; Dinney CP; Malats N; Baris D; Purdue M; Jacobs EJ; Albanes D; Wang Z; Deng X; Chung CC; Tang W; Bas Bueno-de-Mesquita H; Trichopoulos D; Ljungberg B; Clavel-Chapelon F; Weiderpass E; Krogh V; Dorronsoro M; Travis R; Tjønneland A; Brenan P; Chang-Claude J; Riboli E; Conti D; Gago-Dominguez M; Stern MC; Pike MC; Van Den Berg D; Yuan JM; Hohensee C; Rodabough R; Cancel-Tassin G; Roupret M; Comperat E; Chen C; De Vivo I; Giovannucci E; Hunter DJ; Kraft P; Lindstrom S; Carta A; Pavanello S; Arici C; Mastrangelo G; Kamat AM; Lerner SP; Barton Grossman H; Lin J; Gu J; Pu X; Hutchinson A; Burdette L; Wheeler W; Kogevinas M; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Schwenn M; Karagas MR; Johnson A; Schned A; Armenti KR; Hosain GM; Andriole G; Grubb R; Black A; Ryan Diver W; Gapstur SM; Weinstein SJ; Virtamo J; Haiman CA; Landi MT; Caporaso N; Fraumeni JF; Vineis P; Wu X; Silverman DT; Chanock S; Rothman N
    Hum Mol Genet; 2014 Mar; 23(5):1387-98. PubMed ID: 24163127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci.
    Zhou L; Fu G; Wei J; Shi J; Pan W; Ren Y; Xiong X; Xia J; Shen Y; Li H; Yang M
    Oncotarget; 2016 Feb; 7(5):5495-506. PubMed ID: 26716642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.
    Haiman CA; Chen GK; Vachon CM; Canzian F; Dunning A; Millikan RC; Wang X; Ademuyiwa F; Ahmed S; Ambrosone CB; Baglietto L; Balleine R; Bandera EV; Beckmann MW; Berg CD; Bernstein L; Blomqvist C; Blot WJ; Brauch H; Buring JE; Carey LA; Carpenter JE; Chang-Claude J; Chanock SJ; Chasman DI; Clarke CL; Cox A; Cross SS; Deming SL; Diasio RB; Dimopoulos AM; Driver WR; Dünnebier T; Durcan L; Eccles D; Edlund CK; Ekici AB; Fasching PA; Feigelson HS; Flesch-Janys D; Fostira F; Försti A; Fountzilas G; Gerty SM; ; Giles GG; Godwin AK; Goodfellow P; Graham N; Greco D; Hamann U; Hankinson SE; Hartmann A; Hein R; Heinz J; Holbrook A; Hoover RN; Hu JJ; Hunter DJ; Ingles SA; Irwanto A; Ivanovich J; John EM; Johnson N; Jukkola-Vuorinen A; Kaaks R; Ko YD; Kolonel LN; Konstantopoulou I; Kosma VM; Kulkarni S; Lambrechts D; Lee AM; Marchand LL; Lesnick T; Liu J; Lindstrom S; Mannermaa A; Margolin S; Martin NG; Miron P; Montgomery GW; Nevanlinna H; Nickels S; Nyante S; Olswold C; Palmer J; Pathak H; Pectasides D; Perou CM; Peto J; Pharoah PD; Pooler LC; Press MF; Pylkäs K; Rebbeck TR; Rodriguez-Gil JL; Rosenberg L; Ross E; Rüdiger T; Silva Idos S; Sawyer E; Schmidt MK; Schulz-Wendtland R; Schumacher F; Severi G; Sheng X; Signorello LB; Sinn HP; Stevens KN; Southey MC; Tapper WJ; Tomlinson I; Hogervorst FB; Wauters E; Weaver J; Wildiers H; Winqvist R; Van Den Berg D; Wan P; Xia LY; Yannoukakos D; Zheng W; Ziegler RG; Siddiq A; Slager SL; Stram DO; Easton D; Kraft P; Henderson BE; Couch FJ
    Nat Genet; 2011 Oct; 43(12):1210-4. PubMed ID: 22037553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
    Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.